Oral delivery of insulin using pH-responsive complexation gels

被引:319
作者
Lowman, AM
Morishita, M
Kajita, M
Nagai, T
Peppas, NA [1 ]
机构
[1] Purdue Univ, Sch Chem Engn, Biomat & Drug Delivery Labs, W Lafayette, IN 47907 USA
[2] Hoshi Univ, Dept Pharmaceut, Tokyo 142, Japan
关键词
D O I
10.1021/js980337n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The goal of oral insulin delivery devices is to protect the sensitive drug from proteolytic degradation in the stomach and upper portion of the small intestine. In this work, we investigate the use of pH-responsive, poly(methacrylic-g-ethylene glycol) hydrogels as oral delivery vehicles for insulin. Insulin was loaded into polymeric microspheres and administered orally to healthy and diabetic Wistar rats, In the acidic environment of the stomach, the gels were unswollen due to the formation of intermolecular polymer complexes. The insulin remained in the gel and was protected from proteolytic degradation. In the basic and neutral environments of the intestine, the complexes dissociated which resulted in rapid gel swelling and insulin release. Within 2 h of administration of the insulin-containing polymers, strong dose-dependent hypoglycemic effects were observed in both healthy and diabetic rats. These effects lasted for up to 8 h following administration.
引用
收藏
页码:933 / 937
页数:5
相关论文
共 26 条
  • [1] BEKTUROV EA, 1981, ADV POLYM SCI, V41, P99
  • [2] CAMPBELL RK, 1993, NEW OPPORTUNITITES D
  • [3] COSTANTINO HR, 1997, THERAPEUTIC PROTEIN, P29
  • [4] PREPARATION OF POLY(METHACRYLIC ACID-G-ETHYLENE OXIDE) MICROSPHERES
    DRUMMOND, RK
    KLIER, J
    ALAMEDA, JA
    PEPPAS, NA
    [J]. MACROMOLECULES, 1989, 22 (09) : 3816 - 3818
  • [5] ENDE MTA, 1997, PROTEIN DELIVERY PHY, P139
  • [6] Oral controlled release technology for peptides: Status and future prospects
    Fix, JA
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (12) : 1760 - 1764
  • [7] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [8] Harris J.M., 1992, Polyethylene Glycol: Chemistry and Biological Applications
  • [9] The challenge of proteolytic enzymes in intestinal peptide delivery
    Langguth, P
    Bohner, V
    Heizmann, J
    Merkle, HP
    Wolffram, S
    Amidon, GL
    Yamashita, S
    [J]. JOURNAL OF CONTROLLED RELEASE, 1997, 46 (1-2) : 39 - 57
  • [10] Lee VH, 1991, PEPTIDE PROTEIN DRUG, P691